Baxter Hlthcare patents expiration
1. Brevibloc patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
BREVIBLOC family patents
2. Brevibloc Double Strength In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER family patents
3. Brevibloc In Plastic Container patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6310094 | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jan, 2021
(3 years ago) | |
| US6528540 | BAXTER HLTHCARE | Esmolol formulation |
Jan, 2021
(3 years ago) | |
|
US6310094 (Pediatric) | BAXTER HLTHCARE | Ready-to-use esmolol solution |
Jul, 2021
(2 years ago) | |
|
US6528540 (Pediatric) | BAXTER HLTHCARE | Esmolol formulation |
Jul, 2021
(2 years ago) | |
Drugs and Companies using ESMOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 15 August, 1988
Treatment: NA
Dosage: INJECTABLE;INJECTION
BREVIBLOC IN PLASTIC CONTAINER family patents
4. Extraneal patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6077836 | BAXTER HLTHCARE | Peritoneal dialysis and compositions for use therein |
Jun, 2017
(6 years ago) | |
| US6248726 | BAXTER HLTHCARE | Method of peritoneal dialysis using glucose polymer solutions |
Jun, 2018
(5 years ago) | |
Drugs and Companies using ICODEXTRIN ingredient
Market Authorisation Date: 20 December, 2002
Treatment: Peritoneal dialysis solution
Dosage: SOLUTION;INTRAPERITONEAL
EXTRANEAL family patents
5. Nexterone patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6869939 | BAXTER HLTHCARE | Formulations containing amiodarone and sulfoalkyl ether cyclodextrin |
May, 2022
(1 year, 11 months ago) | |
| US7635773 | BAXTER HLTHCARE | Sulfoalkyl ether cyclodextrin compositions |
Mar, 2029
(4 years from now) | |
Drugs and Companies using AMIODARONE HYDROCHLORIDE ingredient
Market Authorisation Date: 24 December, 2008
Treatment: NA
Dosage: INJECTABLE;INJECTION
NEXTERONE family patents
6. Suprane patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5617906 | BAXTER HLTHCARE | Container for anaesthetic agent |
Apr, 2014
(10 years ago) | |
|
US5617906 (Pediatric) | BAXTER HLTHCARE | Container for anaesthetic agent |
Oct, 2014
(9 years ago) | |
Drugs and Companies using DESFLURANE ingredient
Market Authorisation Date: 18 September, 1992
Treatment: NA
Dosage: LIQUID;INHALATION
SUPRANE family patents